Ochre Bio

Active

RNA medicines for liver diseases

What it does

Ochre Bio is a biotechnology company developing RNA medicines for chronic liver diseases.

Its site says now · captured 2026-08-23

Ochre Bio

Ochre Bio is developing therapies for the biggest liver health challenges.

Next to it in Healthcare and bio · RNA therapeutics for liver disease

  • Altay TherapeuticsY Combinator W20

    Altay develops disease-modifying therapies targeting transcription…

  • Gerostate AlphaY Combinator S18

    Developing novel therapeutics for aging and chronic disease

  • NephrogenY Combinator S20

    Curative genetic medicines for kidney diseases

  • Serna BioY Combinator W21

    Genetic Medicine with Small Molecules

  • Equator TherapeuticsY Combinator W20

    We are developing a drug to burn calories and increase metabolism…

  • OpenBiomeY Combinator W20

    A nonprofit stool bank enabling access to fecal transplants.

  • Proteinea500 Global

    Developer of a biotechnology platform intended to integrate biology with engineering and molecular sciences to make protein therapeutics. The company's platform provides traceable, recycled food such as fruits, vegetables, and grains to feed the insects and aims to replace fish meal in aquaculture and animal feed with sustainable alternatives, enabling customers to access an environmentally responsible approach, reduce the volume in landfills while delivering high-quality nutrients for animal and pet food.

  • ViAn TherapeuticsSOSV SOSV IndieBio SF 14

    Topical antiangiogenic peptide for retinal vascular diseases